JP2023522676A5 - - Google Patents
Info
- Publication number
- JP2023522676A5 JP2023522676A5 JP2022563172A JP2022563172A JP2023522676A5 JP 2023522676 A5 JP2023522676 A5 JP 2023522676A5 JP 2022563172 A JP2022563172 A JP 2022563172A JP 2022563172 A JP2022563172 A JP 2022563172A JP 2023522676 A5 JP2023522676 A5 JP 2023522676A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence number
- polypeptide
- less
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014090P | 2020-04-22 | 2020-04-22 | |
| US63/014,090 | 2020-04-22 | ||
| US202063014573P | 2020-04-23 | 2020-04-23 | |
| US63/014,573 | 2020-04-23 | ||
| PCT/US2021/028679 WO2021216899A1 (en) | 2020-04-22 | 2021-04-22 | Il4/il13 receptor molecules for veterinary use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522676A JP2023522676A (ja) | 2023-05-31 |
| JP2023522676A5 true JP2023522676A5 (https=) | 2024-05-02 |
| JP7821741B2 JP7821741B2 (ja) | 2026-02-27 |
Family
ID=78270112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563172A Active JP7821741B2 (ja) | 2020-04-22 | 2021-04-22 | 動物用のｉｌ４／ｉｌ１３受容体分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240270819A1 (https=) |
| EP (1) | EP4139344A4 (https=) |
| JP (1) | JP7821741B2 (https=) |
| KR (1) | KR20230005880A (https=) |
| CN (1) | CN116034112A (https=) |
| AU (1) | AU2021259785A1 (https=) |
| BR (1) | BR112022021204A2 (https=) |
| CA (1) | CA3173927A1 (https=) |
| MX (1) | MX2022013149A (https=) |
| WO (1) | WO2021216899A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| JP7657548B2 (ja) | 2017-04-21 | 2025-04-07 | エランコ・ユーエス・インコーポレイテッド | 獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子 |
| US12297272B2 (en) | 2017-08-15 | 2025-05-13 | Eianco US inc. | IgG Fc variants for veterinary use |
| EP3870601A4 (en) | 2018-10-25 | 2022-07-13 | Kindred Biosciences, Inc. | IL4/IL13 RECEPTOR MOLECULE FOR USE IN VETERINARY MEDICINE |
| WO2025141037A1 (en) * | 2023-12-28 | 2025-07-03 | Elanco Animal Health Gmbh | Il-4/il-13 and il-4/il-13/il-31 receptor trap constructs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998023289A1 (en) * | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
| PL3718564T3 (pl) * | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| EP1723173B1 (en) * | 2004-02-27 | 2008-05-14 | Regeneron Pharmaceuticals, Inc. | Il-4/il-13 specific polypeptides and therapeutic uses thereof |
| EP2596802A1 (en) * | 2011-11-23 | 2013-05-29 | PLS-Design GmbH | Pharmaceutical composition for treatment of allergic reactions |
| US20170290889A1 (en) * | 2016-04-11 | 2017-10-12 | New York University | Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders |
| EP3481413A4 (en) * | 2016-07-08 | 2020-01-08 | Askgene Pharma, Inc. | FUSION PROTEIN WITH LEPTIN AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| US20200181258A1 (en) * | 2016-10-17 | 2020-06-11 | Vetoquinol Sa | Modified antibody constant region |
| JP7657548B2 (ja) * | 2017-04-21 | 2025-04-07 | エランコ・ユーエス・インコーポレイテッド | 獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子 |
| WO2024145280A2 (en) * | 2022-12-27 | 2024-07-04 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| US20240209096A1 (en) * | 2022-12-27 | 2024-06-27 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
-
2021
- 2021-04-22 EP EP21793671.5A patent/EP4139344A4/en active Pending
- 2021-04-22 WO PCT/US2021/028679 patent/WO2021216899A1/en not_active Ceased
- 2021-04-22 US US17/996,549 patent/US20240270819A1/en active Pending
- 2021-04-22 JP JP2022563172A patent/JP7821741B2/ja active Active
- 2021-04-22 BR BR112022021204A patent/BR112022021204A2/pt unknown
- 2021-04-22 AU AU2021259785A patent/AU2021259785A1/en active Pending
- 2021-04-22 MX MX2022013149A patent/MX2022013149A/es unknown
- 2021-04-22 CN CN202180036305.6A patent/CN116034112A/zh active Pending
- 2021-04-22 CA CA3173927A patent/CA3173927A1/en active Pending
- 2021-04-22 KR KR1020227040170A patent/KR20230005880A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522676A5 (https=) | ||
| JP2020517262A5 (https=) | ||
| CN113194984A (zh) | 兽用的与新生儿Fc受体(FcRn)结合改变的Fc变体 | |
| Silacci et al. | Linker length matters, fynomer-Fc fusion with an optimized linker displaying picomolar IL-17A inhibition potency | |
| KR102132997B1 (ko) | Cd40l 특이적 tn3 유래 스카폴드 및 이의 사용 방법 | |
| JP2024026255A5 (https=) | ||
| IL276286B2 (en) | FC variants with improved binding to FCRN and extended half-life | |
| JP2012515556A5 (https=) | ||
| CN101704879A (zh) | 具有改进的特异性的新型免疫球蛋白结合蛋白 | |
| CN110573626B (zh) | 抗体选择方法 | |
| JP2005046146A5 (https=) | ||
| Paudyal et al. | Fc-mediated functions of porcine IgG subclasses | |
| Patel et al. | Sequence of the dog immunoglobulin alpha and epsilon constant region genes | |
| JP7411264B2 (ja) | 新規抗ｐａｄ２抗体 | |
| Taylor et al. | Avian IgY binds to a monocyte receptor with IgG-like kinetics despite an IgE-like structure | |
| CN108290928B (zh) | 卷曲螺旋连接体 | |
| JP2023524643A5 (https=) | ||
| KR20250057131A (ko) | 수의학 용도를 위한 il4/il13 수용체 분자 | |
| CN116034112A (zh) | 兽用il4/il13受体分子 | |
| JP2024507693A (ja) | 二重特異性抗体 | |
| Noble et al. | Distinct effector functions mediated by Fc regions of bovine IgG subclasses and their interaction with Fc gamma receptors | |
| JP2023109920A (ja) | 抗体ＦｃＲｎ結合の改変 | |
| RU2009126545A (ru) | МУЛЬТИМЕРНЫЕ ПОЛИПЕПТИДЫ Fc-РЕЦЕПТОРА, ВКЛЮЧАЮЩИЕ МОДИФИЦИРОВАННЫЙ Fc-ДОМЕН | |
| JP2019172702A (ja) | 目的とする含量で不純物を含むＴＮＦＲ−Ｆｃ融合タンパク質の製造方法 | |
| CN120187749A (zh) | 具有可活化效应结构域的重组结合蛋白 |